Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Head & Neck 7CNS 7Tumor-Agnostic 6Other hematologic neoplasm 6Gynecologic 6Gastrointestinal 6Lymphoid 4Genitourinary 3Dermatologic 3Sarcoma 2Other solid neoplasm 2Plasma cell 1Other 1Endocrine 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 2

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Restraint, Physical × Other solid neoplasm × Clear all
NCT07225920 2026-04-08

PGA

Wake Forest University Health Sciences

Phase NA Enrolling by invitation
216 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06582030 2024-09-03

Stop Addiction Stigma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
93 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡